Bortenat 3.5mg Injection

Produktübersicht

About Bortenat

Bortenat is a medication containing the active ingredient bortezomib, classified as Proteasome Inhibitor. Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Bortezomib for injection is a proteasome inhibitor indicated for: • treatment of adult patients with multiple myeloma ( 1
• Used for: 1 ) • treatment of adult patients with mantle cell lymphoma ( 1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

bortezomib, the active ingredient in Bortenat, belongs to the Proteasome Inhibitor class. 1 INDICATIONS AND USAGE Bortezomib for injection is a proteasome inhibitor indicated for: • treatment of adult patients with multiple myeloma ( 1. 1 ) • treatment of adult patients with mantle cell lymphoma ( 1. 2 ) 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Bortenat. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Bortenat for extended periods without medical advice.